| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1084537988 |
| P356 | DOI | 10.1038/S41598-017-00977-0 |
| P932 | PMC publication ID | 5429799 |
| P698 | PubMed publication ID | 28405010 |
| P2093 | author name string | Guo-Ping Shi | |
| Galina K Sukhova | |||
| Cong-Lin Liu | |||
| Jin-Ying Zhang | |||
| Mengyang Liao | |||
| Cleverson Fernandes | |||
| Karine Iamarene | |||
| Marcela M Santos | |||
| P2860 | cites work | European Journal of Immunology | Q5412727 |
| Human cathepsin S: chromosomal localization, gene structure, and tissue distribution | Q24310666 | ||
| Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 | ||
| Recognition of single-stranded RNA viruses by Toll-like receptor 7 | Q24568101 | ||
| Unexpected protective role for Toll-like receptor 3 in the arterial wall | Q24624935 | ||
| Matrix metalloproteinase interactions with collagen and elastin | Q26996437 | ||
| The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors | Q27860900 | ||
| Pathogen recognition and innate immunity | Q27861084 | ||
| Emerging risk biomarkers in cardiovascular diseases and disorders | Q28081614 | ||
| The complement system and toll-like receptors as integrated players in the pathophysiology of atherosclerosis | Q28083548 | ||
| Emerging roles for cysteine proteases in human biology | Q28306260 | ||
| Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice | Q28591350 | ||
| Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice | Q34142722 | ||
| Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management | Q34181381 | ||
| Compensatory enlargement of human atherosclerotic coronary arteries | Q34184275 | ||
| Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice | Q34236802 | ||
| Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice | Q34555906 | ||
| Cathepsin L activity controls adipogenesis and glucose tolerance | Q34654358 | ||
| Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease | Q34755816 | ||
| Measurement of matrix metalloproteinase 9-mediated collagen type III degradation fragment as a marker of skin fibrosis | Q34769928 | ||
| TLR7 and CD40 cooperate in IL-6 production via enhanced JNK and AP-1 activation. | Q40019462 | ||
| Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12. | Q40084538 | ||
| Quantitative analysis and characterization of atherosclerotic lesions in the murine aortic sinus | Q40289404 | ||
| Inhibition of glycosphingolipid synthesis ameliorates atherosclerosis and arterial stiffness in apolipoprotein E-/- mice and rabbits fed a high-fat and -cholesterol diet. | Q40578811 | ||
| Guanosine and its modified derivatives are endogenous ligands for TLR7. | Q41195915 | ||
| Viral RNA in the influenza vaccine may have contributed to the development of ANCA-associated vasculitis in a patient following immunisation | Q41371533 | ||
| Hepatitis C virus RNA localization in human carotid plaques | Q42992549 | ||
| Active cytomegalovirus replication in patients with coronary disease | Q43415680 | ||
| Regulatory T cells prevent plaque disruption in apolipoprotein E-knockout mice. | Q43751792 | ||
| The effect of TLR4/7 on the TGF-β-induced Smad signal transduction pathway in human keloid | Q44259971 | ||
| HCV infection facilitates asymptomatic carotid atherosclerosis: preliminary report of HCV RNA localization in human carotid plaques. | Q44658074 | ||
| Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth | Q45873353 | ||
| Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet | Q46129274 | ||
| Toll-like receptor 7 cooperates with IL-4 in activated B cells through antigen receptor or CD38 and induces class switch recombination and IgG1 production | Q46154630 | ||
| Role of cathepsin S-dependent epithelial cell apoptosis in IFN-gamma-induced alveolar remodeling and pulmonary emphysema | Q46535470 | ||
| Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice | Q46689553 | ||
| Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells | Q47833171 | ||
| Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. | Q51561712 | ||
| Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. | Q51679983 | ||
| Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis. | Q51830691 | ||
| Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology. | Q52589485 | ||
| Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice. | Q53072350 | ||
| Toll-Like Receptor 7 Protects From Atherosclerosis by Constraining “Inflammatory” Macrophage Activation | Q57315829 | ||
| Blocking Toll-Like Receptors 7 and 9 Reduces Postinterventional Remodeling via Reduced Macrophage Activation, Foam Cell Formation, and Migration | Q63915472 | ||
| Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice. | Q64885339 | ||
| Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse | Q74172824 | ||
| Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells | Q78806915 | ||
| Natural and synthetic TLR7 ligands inhibit CpG-A- and CpG-C-oligodeoxynucleotide-induced IFN-alpha production | Q79984758 | ||
| Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs | Q83790498 | ||
| Toll-like receptor 7 stimulation by imiquimod induces macrophage autophagy and inflammation in atherosclerotic plaques | Q84032992 | ||
| Development and validation of an enzyme-linked immunosorbent assay for the quantification of a specific MMP-9 mediated degradation fragment of type III collagen--A novel biomarker of atherosclerotic plaque remodeling | Q84057841 | ||
| Specific loss of toll-like receptor 2 on bone marrow derived cells decreases atherosclerosis in LDL receptor null mice | Q84898284 | ||
| Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice | Q34967612 | ||
| IRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupus-associated atherosclerosis | Q35070231 | ||
| IL-4 suppresses the responses to TLR7 and TLR9 stimulation and increases the permissiveness to retroviral infection of murine conventional dendritic cells | Q35086719 | ||
| Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. | Q35763570 | ||
| Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme | Q35796049 | ||
| Proinflammatory Stimulation of Toll-Like Receptor 9 with High Dose CpG ODN 1826 Impairs Endothelial Regeneration and Promotes Atherosclerosis in Mice | Q35889971 | ||
| Toll-Like Receptor 9 Inactivation Alleviated Atherosclerotic Progression and Inhibited Macrophage Polarized to M1 Phenotype in ApoE-/- Mice | Q35898043 | ||
| Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice | Q36025276 | ||
| Protective role for TLR4 signaling in atherosclerosis progression as revealed by infection with a common oral pathogen | Q36252511 | ||
| Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates | Q36305029 | ||
| Allergic Lung Inflammation Aggravates Angiotensin II-Induced Abdominal Aortic Aneurysms in Mice. | Q36403301 | ||
| RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. | Q36403678 | ||
| Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids. | Q36459911 | ||
| Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis | Q36638113 | ||
| Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E | Q36986664 | ||
| Toll-like receptor 4 deficiency decreases atherosclerosis but does not protect against inflammation in obese low-density lipoprotein receptor-deficient mice | Q37108936 | ||
| TLR3 deficiency protects against collagen degradation and medial destruction in murine atherosclerotic plaques | Q37166308 | ||
| Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice | Q37330834 | ||
| Vessel-specific Toll-like receptor profiles in human medium and large arteries | Q37357843 | ||
| Collagens in the progression and complications of atherosclerosis | Q37368729 | ||
| Innate immunity and toll-like receptor antagonists: a potential role in the treatment of cardiovascular diseases | Q37474985 | ||
| Blocking TLR2 activity diminishes and stabilizes advanced atherosclerotic lesions in apolipoprotein E-deficient mice | Q37729330 | ||
| Diet, commensals and the intestine as sources of pathogen-associated molecular patterns in atherosclerosis, type 2 diabetes and non-alcoholic fatty liver disease. | Q37858022 | ||
| Pattern recognition receptors and the innate immune response to viral infection | Q37945230 | ||
| Functions of TGF-β-exposed plasmacytoid dendritic cells. | Q38083330 | ||
| Toll-like receptors in atherosclerosis: a 'Pandora's box' of advances and controversies | Q38153941 | ||
| TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals | Q38173691 | ||
| Toll-like receptor signaling pathways | Q38259564 | ||
| Vascular smooth muscle cell in atherosclerosis | Q38353932 | ||
| Toll-like receptor 7 promotes the apoptosis of THP-1-derived macrophages through the CHOP-dependent pathway. | Q38978156 | ||
| The activation of TLR7 regulates the expression of VEGF, TIMP1, MMP2, IL-6, and IL-15 in Hela cells | Q39042435 | ||
| TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice. | Q39260793 | ||
| Increased cytokine response after toll-like receptor stimulation in patients with stable coronary artery disease | Q39309499 | ||
| Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin | Q39705893 | ||
| Tumour-derived prostaglandin E and transforming growth factor-beta synergize to inhibit plasmacytoid dendritic cell-derived interferon-alpha | Q39753147 | ||
| Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma. | Q39932147 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | toll-like receptor | Q408004 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 847 | |
| P577 | publication date | 2017-04-12 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Toll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosis | |
| P478 | volume | 7 |
| Q93089064 | RNAs and RNA-Binding Proteins in Immuno-Metabolic Homeostasis and Diseases |
| Q99591180 | The Anti-Inflammatory Effect of Taurine on Cardiovascular Disease |
| Q93046260 | Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel |
| Q98771780 | When Innate Immunity Meets Angiogenesis-The Role of Toll-Like Receptors in Endothelial Cells and Pulmonary Hypertension |
Search more.